Palmitoylethanolamide and Its Biobehavioral Correlates in Autism Spectrum Disorder: A Systematic Review of Human and Animal Evidence
Autism spectrum disorder (ASD) pathophysiology is not completely understood; however, altered inflammatory response and glutamate signaling have been reported, leading to the investigation of molecules targeting the immune-glutamatergic system in ASD treatment. Palmitoylethanolamide (PEA) is a natur...
Main Authors: | Marco Colizzi, Riccardo Bortoletto, Rosalia Costa, Leonardo Zoccante |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/13/4/1346 |
Similar Items
-
The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity
by: Sachin Patel, et al.
Published: (2005-02-01) -
The History and Significance of the Autism Spectrum
by: Atkins, Walter Earl, Jr
Published: (2011) -
Autism: epileptiform discharge in EEG with and without seizure disorder
by: Bobby Hmar
Published: (2016-07-01) -
Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide?
by: Giorgia della Rocca, et al.
Published: (2021-03-01) -
Gender Bias in Autism Spectrum Disorders- A Review
by: Abhinob Baruah, et al.
Published: (2018-04-01)